Blood News and Research

RSS

NIEHS announces finalists of My Air, My Health Challenge

Four finalists have been selected in the My Air, My Health Challenge, sponsored by the National Institutes of Health (NIH) and its challenge partners. Each finalist will receive $15,000, and will transform their designs to measure air pollutants and related physiological measurements into working systems. One overall winner will receive a cash award of $100,000 to be announced in June 2013.

16 Nov 2012

CLR01 effectively inhibits synaptotoxicity in mice with Alzheimer's

Last March, researchers at UCLA reported the development of a molecular compound called CLR01 that prevented toxic proteins associated with Parkinson's disease from binding together and killing the brain's neurons.

16 Nov 2012

New insights into how MSCs ‘traffic’ from the circulation into tissues

Mesenchymal stem cells (MSCs), are a newly emerging cellular therapy being tested in approximately 250 clinical trials worldwide to help repair damaged tissues, such as injured heart muscle following a heart attack. The problem is that when culture-expanded MSCs are injected into the circulation, they have trouble gaining access to the inflamed tissues-exactly where their help is needed.

16 Nov 2012

Researchers develop catheter that can perform triple-duty during cardiac ablation surgery

Researchers at the McCormick School of Engineering are part of a team that has used stretchable electronics to create a multipurpose medical catheter that can both monitor heart functions and perform corrections on heart tissue during surgery.

16 Nov 2012

Peak interest in health issues comes at about age 51 for baby boomers

For baby boomers, the peak interest in health issues comes at about age 51, with a second peak coming near age 65, according to a new study.

16 Nov 2012

Study finds mechanism that mediates inhibition of critical breathing muscles during REM sleep

A novel brain mechanism mediating the inhibition of the critical breathing muscles during rapid eye movement (REM) sleep has been identified for the first time in a new study, offering the possibility of a new treatment target for sleep-related breathing problems.

16 Nov 2012

AGT2R gene variant may predispose women to pre-eclampsia

New research at the University of Adelaide has revealed a genetic link in pregnant mums - and their male partners - to pre-eclampsia, a life-threatening complication during pregnancy.

16 Nov 2012

People with Prader-Willi Syndrome may have impaired autonomic nervous system

An Australian study reveals that people with the rare genetic disorder known as Prader-Willi Syndrome may have an impaired autonomic nervous system. This discovery opens up a new way of looking at the insatiable appetite experienced by all sufferers, as well as their very high risk of cardiovascular disease.

16 Nov 2012

Study looks at health outcomes of kidney transplant recipients with low donor-specific antibodies

Kidney transplant recipients who have even very low levels of preformed antibodies directed against a donated kidney have a significantly increased risk of organ rejection and kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

16 Nov 2012

High risk CVD patients more likely to receive prescriptions for cholesterol-lowering drugs

In a new study, Northwestern Medicine researchers found that patients at high risk for cardiovascular disease (CVD) are more likely to receive a prescription for cholesterol-lowering medication, and to achieve lower long-term cholesterol levels, when doctors use electronic health records (EHRs) to deliver personalized risk assessments via mail.

16 Nov 2012

Positive results from POZEN’s PA8140-102 Phase 1 bioavailability study

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today that the results from a Phase 1 study, PA8140-102, demonstrated that PA8140, POZEN's proprietary combination of aspirin (81 mg) and omeprazole (40 mg), had comparable bioavailability relative to the reference listed product, enteric-coated (EC) aspirin (81 mg).

16 Nov 2012

Study finds specific way in which Salmonella counteract defense mechanisms of human cells

A new study by researchers at Imperial College London has identified a way in which Salmonella bacteria, which cause gastroenteritis and typhoid fever, counteract the defence mechanisms of human cells.

16 Nov 2012

Longer looks: A dentist tries to clear his debt; Bringing mental health services to the marines; Learning to laugh in the doctor's office

His jaw clenched beneath a blue surgeon's mask, Opanin Gyaami jerks his right arm and pulls out a prize: the decayed tooth of patient Larry Butler, also known as state prison inmate J22312. By the time he is done, Gyaami's smock and mask are spotted with the inmate's blood. He gently pats Butler on the shoulder and wishes him well.

16 Nov 2012

Cook receives FDA approval for Zilver PTX Drug-Eluting Peripheral Stent to treat PAD

The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked as a result of peripheral artery disease (PAD).

15 Nov 2012

RXi announces pharmacokinetic results from RXI-109 Phase 1 study in healthy subjects

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the pharmacokinetic results of their single dose Phase 1 study with RXI-109 in healthy subjects.

15 Nov 2012

Link between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes

A study led by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes.

15 Nov 2012

Hearing impairment risk high with diabetes

People with diabetes are at high risk for developing a hearing impairment, report researchers.

15 Nov 2012

Omron launches continuous Strapless Heart Rate Monitor

Today Omron Healthcare, Inc., a leader in personal wellness products, launched its first-ever, continuous Strapless Heart Rate Monitor (HR-500U). Exercise enthusiasts can now take their workout to the next level comfortably without an annoying chest strap. Easy to use, the monitor is worn on the wrist and provides accurate, continuous monitoring.

15 Nov 2012

Simple ways to reduce risk of lung cancer

More than an estimated 160,000 people in the United States will die from lung cancer this year, making it the country's leading cause of cancer death. According to the National Cancer Institute, it surpassed breast cancer as the number one killer in women back in 1987. It causes more deaths than colon, breast and prostate cancer combined, according to the American Lung Association. Bruce Johnson, MD, the director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, sorts out the facts about lung cancer and offers simple ways to reduce risk.

15 Nov 2012

Over stress during pregnancy increases risk of child being victimised in later life

Children whose mothers were overly stressed during pregnancy are more likely to become victims of bullying at school.

15 Nov 2012

Blood News and Research

NIEHS announces finalists of My Air, My Health Challenge

CLR01 effectively inhibits synaptotoxicity in mice with Alzheimer's

New insights into how MSCs ‘traffic’ from the circulation into tissues

Researchers develop catheter that can perform triple-duty during cardiac ablation surgery

Peak interest in health issues comes at about age 51 for baby boomers

Study finds mechanism that mediates inhibition of critical breathing muscles during REM sleep

AGT2R gene variant may predispose women to pre-eclampsia

People with Prader-Willi Syndrome may have impaired autonomic nervous system

Study looks at health outcomes of kidney transplant recipients with low donor-specific antibodies

High risk CVD patients more likely to receive prescriptions for cholesterol-lowering drugs

Positive results from POZEN’s PA8140-102 Phase 1 bioavailability study

Study finds specific way in which Salmonella counteract defense mechanisms of human cells

Longer looks: A dentist tries to clear his debt; Bringing mental health services to the marines; Learning to laugh in the doctor's office

Cook receives FDA approval for Zilver PTX Drug-Eluting Peripheral Stent to treat PAD

RXi announces pharmacokinetic results from RXI-109 Phase 1 study in healthy subjects

Link between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes

Hearing impairment risk high with diabetes

Omron launches continuous Strapless Heart Rate Monitor

Simple ways to reduce risk of lung cancer

Over stress during pregnancy increases risk of child being victimised in later life

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News